BIO
Bio-Rad Laboratories, Inc.Class A
LABORATORY ANALYTICAL INSTRUMENTS
Best Lab Instruments Stocks 2026 →
BIO Stock Analysis: Buy, Sell, or Hold?
$386.48
-1.83 (-0.47%)
▼
5d:
+3.09%
30d:
+6.05%
90d:
+6.74%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (54%)
Quality Score
59/100
Position
EXTENDED
30-Day Fair Range
$360.25 – $380.05
Position: EXTENDED
Forward P/E & Valuation
39.0x
STRETCHED
vs 30.9x historical avg
Wall Street Target
$356.67
-7.7% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$352.09 / $394.73
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: BIO trades at premium valuation expecting 8.1% growth. Hold existing positions but don't chase. Wait for better entry.
Get Alerted When BIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$294.86
Based on 3.6% avg growth
INTRINSIC VALUE TODAY
$183.08
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BIO is currently trading at $386.48, which is considered extended relative to its 30-day fair value range of $360.25 to $380.05. From a valuation perspective, the stock is trading at a premium (Forward PE: 39.0) compared to its historical average (30.9). At these levels, the market is pricing in 8.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, BIO is in a strong uptrend. The price is approaching resistance at $394.73. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BIO is in a strong uptrend. The price is approaching resistance at $394.73. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$360.25 -
$380.05
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
53.8%
Trading Range & Key Levels
30-Day Trading Range
$360.25 -
$380.05
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$19.18
(5.0%)
Support Level
$352.09
Resistance Level
$394.73
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding BIO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (47/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($356.67)
- NEUTRAL: Trading at premium valuation - market expects 8.1% growth which is achievable
- NEUTRAL: Bottoming setup forming (47/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
39.01
Wall Street Target
$356.67
(-7.7%)
Revenue Growth (YoY)
0.5%
Earnings Growth (YoY)
18.7%
Profit Margin
39.5%
Valuation Premium vs History
+8.1% premium
PE vs Historical
39.0 vs 30.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.1%
(market-implied from PE analysis)
1-Year Target
$417.78
(+8%)
2-Year Target
$451.63
(+17%)
3-Year Target
$488.21
(+26%)
3-Yr Target (if PE normalizes)
(PE: 39→31)
PE COMPRESSION
$386.69
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 39.0, Growth: 3.1%)
$423.83
(+10%)
Base:
(SPY PE: 19.9, Growth: 3.1%)
$215.76
(-44%)
Bear:
(PE: 16.9, Growth: 3.1%)
$183.40
(-53%)
📈
Valuation based on Current Earnings
Trailing PE: 10.32 | Current EPS (TTM): $37.64
Bull Case
$213.57
(-45%)
Analyst growth -50.0%, PE expands to 11.4
Base Case
$194.15
(-50%)
Market implied -50.0%, PE stable at 10.3
Bear Case
$264.05
(-32%)
Severe decline -20.0%, PE contracts to 8.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share BIO Analysis
Share this live BIO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BIO)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jul 24, 2026
Daily AI digest
AI Retail Discussion Summary:
Based on the available data from StockTwits and Yahoo Finance, there are no recent news articles related to $BIO and bullish sentiment is dominating social media with a 100.0% share.
Key Retail Themes:
Bullish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 9:20 PM ET
Data refreshes hourly during market hours. Next update: 10:20 PM
Data refreshes hourly during market hours. Next update: 10:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 47 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 42 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 37 SELL |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 31 SELL |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
22 analysts |
$88 | 33 SELL |
Advanced BIO Option Strategies
Professional options setups generated by AI based on today's BIO price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BIO Research Pages
